Kalaris Therapeutics
NASDAQ: KLRS
$2.03
as on
Kalaris Therapeutics Stock Performance
as on October 17, 2026 at 6:59 am IST
Day's Low
Day's High
$2.02$2.29
0.49%
Downside
12.81%
Upside
52 Week's Low
52 Week's High
$2.10$11.88-3.45%
Downside
485.22%
Upside
Kalaris Therapeutics share price movements today
- Previous Close
- $2.19
- Open
- $2.25
- Volume
- 319.2K
- Market Cap
- $50.7M
- Day's Low - High
- $2.02 - $2.29
- 52 Week Low - High
- $2.10 - $11.88
Kalaris Therapeutics Historical Returns
- 1 Month Return
- -31.13 %
- 3 Month Return
- -52.49 %
- 1 Year Return
- -54.28 %
- 3 Year Return
- 0 %
- 5 Year Return
- 0 %
Kalaris Therapeutics Stock Fundamentals & Key Indicators
Check Kalaris Therapeutics market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$50.7M
EPS (TTM)
-2.02
Dividend Yield
0.00%
PE Ratio (TTM)
-1.05
Industry PE ratio
-3.11
PEG Ratio
-0.00
Return On Equity TTM
-71.71%
Kalaris Therapeutics vs Peer Comparison
Compare market cap, revenue, PE, and other key metrics of Kalaris Therapeutics with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % | Dividend Yield % |
|---|---|---|---|---|---|---|
| NA | $50.7M | NA | -1.05 | 0.00% | 0.00% | |
| Neutral | $90.3B | -27.05% | -29.64 | -12.57% | 0.00% | |
| StrongBuy | $126.4B | 179.89% | 28.78 | 86.04% | 0.00% | |
| Buy | $77.5B | 43.94% | 19.01 | 84.86% | 0.48% |
Stock Returns calculator for Kalaris Therapeutics Stock including INR - Dollar returns
The Kalaris Therapeutics stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.
Investment Value
₹1,00,000
Kalaris Therapeutics investment value today
Current value as on today
₹45,737
Returns
Returns from Kalaris Therapeutics Stock
Dollar Impact
₹3,357 (+3.36%)
Indian Investors' Interest in Kalaris Therapeutics Stock
Search interest for Kalaris Therapeutics Stock has decreased by -11% in the last 30 days, reflecting a downward trend in search activity.
Time period: to
Kalaris Therapeutics Quarterly Profit & Loss
All numbers in Millions USD
Kalaris Therapeutics Annual Profit & Loss
All numbers in Millions USD
Kalaris Therapeutics Quarterly Cash Flow
All numbers in Millions USD
Kalaris Therapeutics Annual Cash Flow
All numbers in Millions USD
Insights on Kalaris Therapeutics
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
NO EFFECTAgainst Peers
In the last 1 year, Moderna, Inc. Common Stock has given 771.4% return, outperforming this stock by 825.7%
- NO EFFECT
Against Peers
In the last 3 years, Moderna, Inc. Common Stock has given 157.2% return, outperforming this stock by 251.7%
NEGATIVE IMPACTPrice Dip
In the last 1 month, KLRS stock has moved down by -31.1%
About Kalaris Therapeutics
| Organisation | Kalaris Therapeutics |
| Headquarters | 400 Connell Drive, Berkeley Heights, NJ, 07922, US |
| Industry | Biotechnology |
| CEO | Andrew Oxtoby |
Key Management of Kalaris Therapeutics
Name | Title |
|---|---|
Ms. Kristine Curtiss | Senior Vice President of Clinical |
Dr. Jill E. Porter Ph.D. | Senior Vice President of CMC |
Dr. Napoleone Ferrara M.D. | Independent Director & Co-Founder |
Dr. Matthew Feinsod M.D. | Chief Medical Officer |
Ms. Amy Vandekop | Interim Principal Accounting Officer & Corporate Controller |
Ms. Liisa Ann Bayko M.B.A. | CFO & Treasurer |
Mr. Andrew Oxtoby | President, CEO & Director |
Dr. Srinivas Akkaraju M.D., Ph.D. | Director & Co-Founder |
Dr. Michael Philip Dybbs Ph.D. | Co-Founder & Director |
FAQs
What is Kalaris Therapeutics share price today?
Kalaris Therapeutics share price today is $2.03 as on at the close of the market. Kalaris Therapeutics share today touched a day high of $2.29 and a low of $2.02.
What is the 52 week high and 52 week low for Kalaris Therapeutics share?
Kalaris Therapeutics share touched a 52 week high of $11.88 on and a 52 week low of $2.10 on . Kalaris Therapeutics stock price today i.e. is closed at $2.03,which is 82.91% down from its 52 week high and -3.33% up from its 52 week low.
What is Kalaris Therapeutics's market capitalisation today?
Kalaris Therapeutics market capitalisation is $0.00T as on .
How to invest in Kalaris Therapeutics Stock (KLRS) from India?
- Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
- Step 2: Search for Kalaris Therapeutics on INDmoney app. Click on Buy button.
What is the minimum amount required to buy Kalaris Therapeutics Stock (KLRS) from India?
Indian investors can start investing in Kalaris Therapeutics (KLRS) shares with as little as ₹94.95999908447266 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹949.60 in Kalaris Therapeutics stock (as per the Rupee-Dollar exchange rate as on ).
Based on Kalaris Therapeutics share’s latest price of $2.03 as on October 17, 2026 at 1:29 am IST, you will get 4.9261 shares of Kalaris Therapeutics. Learn more about
fractional shares .